Article Information
History
- March 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Geert Byttebier, MSc1,
- Luc Belmans, MD1,
- Myriam Alexander, PhD2,
- Bo E.H. Saxberg, MD, PhD3,
- Bart De Spiegeleer, PharmD, PhD4,
- Anton De Spiegeleer, MD5,
- Nick Devrecker, MD6,
- Jens T. Van Praet, MD, PhD7,
- Karolien Vanhove, MD, PhD8,
- Reinhilde Reybrouck, MD9,
- Evelien Wynendaele, PharmD, PhD4 and
- David S. Fedson, MD10,*
- 1Medaman BV, Geel, Belgium
- 2Open Health, Marlow, UK
- 3DDO Strategic Services, LLC, US
- 4Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- 5Faculty of Medical & Health Sciences, Ghent University, Ghent, Belgium
- 6AZ Delta, Roeselare, Belgium
- 7Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Belgium
- 8AZ Vesalius, Tongeren, Belgium
- 9RZ Heilig Hart, Tienen, Belgium
- 10Sergy Haut, France
- ↵*Corresponding author: David S. Fedson, MD 57 chemin du Lavoir, 01630 Sergy Haut, France davidsfedson{at}gmail.com Tel: 334.5099.1306